Pharmagest Interactive: Acquisition of Editions Prokov,
Villers-lès-Nancy, September 28, 2021 – 6:00 p.m. (CET)
THE PHARMAGEST GROUP EXTENDS ITS SCOPE
TO INCLUDE MEDICAL SOFTWARE.
ACQUISITION OF PROKOV EDITIONS.
Pharmagest Group (Euronext Paris – Compartment B – ISIN: FR 0012882389), the first supplier health sector software solutions in Europe, today announces the finalization of the acquisition of Prokov Editions, the third independent French publisher of applications for doctors, on the basis of 100% of its capital.
PHARMAGEST extends its scope to general practitioners and specialists
Prokov Editions has an installed application base of 13,000 general practitioners and specialists.
Prokov Editions, a French company founded by Thierry KAUFFMANN in 1987, is the first independent publisher (ISV) of medical software for Mac (the Apple environment is widely used by doctors), but also for iPhone and iPad for mobile solutions, and third largest ISV apps for physicians.
Prokov Editions offers four complementary software packages, covering all the needs of the general practitioner.
All its applications are approved, certified and compatible with all Health Insurance services:
- Its flagship software, MédiStory, is an application for monitoring patient medical records that manages consultations and appointments, prescriptions, reports and integrates messaging.
- The 4e The generation of this application was released in 2020, a state-of-the-art version in a market where most of the IT tools in the medical industry are regulatory-focused and have not been upgraded to support the ” addition of the patient’s medical file. MédiStory 4 already integrates most of the functionalities recommended by the reforms of the French health system (Health Segur 2020, Mom Health 2022).
- Prokov Editions’ offer also includes prescription assistance applications, billing and remote transmission solutions for the Health Insurance smart card (SESAM-Vitale).
Medical software: PHARMAGEST complete its offer
The acquisition of Prokov Editions completes the Pharmagest Group’s range of healthcare software solutions for healthcare professionals and strengthens its position as a key player in the digital healthcare sector.
Reflecting the Group’s strategy to improve the efficiency of patient journeys, this acquisition effectively complements the service offering of its Digital Health Platform. It will also create synergies between all the software in its ecosystem and will greatly facilitate user-friendliness for healthcare professionals.
The addition of this new field of activity will result in the creation, in the coming weeks, of a center bringing together all the business applications intended for private practitioners in private practice.
Commenting on this acquisition, Thierry CHAPUSOT, Chairman of the Board of Directors of the Pharmagest Group declared: “Today, the Pharmagest Group is taking a very important step: we are now able to meet the IT needs of physicians. This acquisition creates value and perfectly meets the needs of healthcare professionals and public authorities in terms of the efficiency of the patient journey. We thank Thierry KAUFFMANN and its teams for the trust they place in us by joining our group. This acquisition is part of our Group’s very ambitious and coherent development plan, both in terms of strategy and business model.“
Thierry KAUFFMANN, President and founder of Editions Prokov added: “For 30 years, healthcare IT business applications have been developed in silos where the needs of each business are addressed by specialized developers. With the development of technologies and digital ecosystems, improving patient care requires healthcare professionals to be connected. It is a chance for Prokov to be able to join a group where there is already a strong transversality between health professionals. Our expertise fits perfectly into this model and will allow us to go even further in this transversal approach. “
- Publication of Q3 2021 revenue: November 10, 2021 (after market close).
- Publication of 2021 annual turnover: February 4, 2022 (after market close).
On Pharmagest Group:
With more than 1,100 employees acting as “Citizens in the service of health and well-being”, the Pharmagest Group is the leading supplier of IT solutions for the health sector in Europe through innovative solutions and services for health professionals guaranteeing the efficiency of the health system. and improving the patient care pathway.
A key player in the quality of care and coordination between private practices and hospitals, the Pharmagest Group is present in France, Italy, Belgium, Luxembourg and the United Kingdom where it is developing the first healthcare platform and a unique ecosystem for France and Europe, putting the best of technology at the service of people.
Listed on Euronext Paris ™ – Compartment B
Indices: MSCI GLOBAL SMALL CAP – GAÏA 20 Index20 – CAC® PETIT and CAC® All-negotiable
Included under the European Rising Tech label.
Eligible for the “long-only” Deferred Settlement Service (SRD) and share savings accounts invested in small and uppercase averages (PEA-PME).
ISIN: FR 0012882389 – Reuters: PHA.PA – Bloomberg: – PMGI FP
For all the latest news, visit www.pharmagest.com
Follow Pharmagest on Twitter: @Pharmagest, LinkedIn and Facebook
Analyst and investor relations:
Administrative and Financial Director: Jean-Yves SAMSON
Phone. +33 (0) 3 83 15 90 67 – [email protected]
FIN’EXTENSO – Isabelle APRILE
Phone. +33 (0) 1 39 97 61 22 – [email protected]